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Abstract. Unsupervised learning can discover various unseen diseases, relying on large-
scale unannotated medical images of healthy subjects. Towards this, unsupervised meth-
ods reconstruct a single medical image to detect outliers either in the learned feature space
or from high reconstruction loss. However, without considering continuity between multi-
ple adjacent images, they cannot directly discriminate diseases composed of the accumu-
lation of subtle anatomical anomalies, such as Alzheimer’s Disease (AD). Moreover, no
study shows how unsupervised anomaly detection is associated with disease stages. There-
fore, we propose a two-step method using Generative Adversarial Network-based multiple
adjacent brain MRI slice reconstruction to detect AD at various stages: (Reconstruction)
Wasserstein loss with Gradient Penalty + `1 loss—trained on 3 healthy slices to reconstruct
the next 3 ones—reconstructs unseen healthy/AD cases; (Diagnosis) Average/Maximum
loss (e.g., `2 loss) per scan discriminates them, comparing the reconstructed/ground truth
images. The results show that we can reliably detect AD at a very early stage with Area
Under the Curve (AUC) 0.780 while also detecting AD at a late stage much more accu-
rately with AUC 0.917; since our method is unsupervised, it should also discover and alert
any anomalies including rare disease.
1 Scientific Background
Deep Learning can achieve accurate computer-assisted diagnosis when large-scale an-
notated training samples are available [1]. In medical imaging, unfortunately, preparing
such massive annotated datasets is often impossible; to tackle this, researchers have pro-
posed various data augmentation techniques, including Generative Adversarial Network
(GAN)-based ones [2, 3, 4]. However, even exploiting these techniques, supervised learn-
ing still requires many pathological images, even for rare disease, to conduct reliable diag-
nosis; nevertheless, it can only detect already-learned specific pathologies. In this regard,
as physicians detect unseen anomalies using prior information on healthy body structure,
unsupervised anomaly detection methods leveraging only large-scale healthy images can
discover and alert unseen disease when their generalization fails.
Towards this, researchers reconstructed a single medical image via GANs [5], AutoEn-
coders (AEs) [6, 7], or combining them [8], since GANs can generate realistic images and
ar
X
iv
:1
90
6.
06
11
4v
4 
 [e
es
s.I
V]
  8
 Ju
l 2
01
9
Proceedings of CIBB 2019 2
Train
Infer
Train GAN to reconstruct next 3 healthy
MRI slices from previous 3 ones
Based on reconstruction, classify MRI
scans into healthy/Alzhheimer’s disease
Unseen
3 slices
Next
3 slices
Compare average/maximum
loss per scan
Reconstructed
3 slices
Figure 1: Unsupervised AD diagnosis framework: We train WGAN-GP + `1 loss on 3 healthy
brain axial MRI slices to reconstruct the next 3 ones, and test it on both unseen healthy and AD
cases to classify them based on average/maximum loss (e.g., `2 loss) per scan.
AEs, especially Variational AEs [9], can directly map data onto its latent representation;
then, unseen images were scored by comparing them with reconstructed ones to discrim-
inate a pathological image distribution (i.e., outliers either in the learned feature space
or from high reconstruction loss). However, those single image reconstruction methods
mainly target diseases easy-to-detect from a single image even for non-expert humans,
such as glioblastomas on Magnetic Resonance (MR) images [10] and lung cancers on
Computed Tomography images [11]. Without considering continuity between multiple
adjacent images, they cannot directly discriminate diseases composed of the accumulation
of subtle anatomical anomalies, such as Alzheimer’s Disease (AD). Moreover, no study
shows how unsupervised anomaly detection is associated with disease stages.
We thus propose a two-step method using GAN-based multiple adjacent brain MRI
slice reconstruction to detect AD at various stages (Fig. 1): (Reconstruction) Wasserstein
loss with Gradient Penalty (WGAN-GP) [12] + `1 loss—trained on 3 healthy brain axial
MRI slices to reconstruct the next 3 ones—reconstructs unseen healthy/AD cases; (Di-
agnosis) Average/Maximum loss (e.g., `2 loss) per scan discriminates them, comparing
the reconstructed/ground truth images. Using 1, 133 healthy MRI scans for training, our
approach can reliably detect AD at a very early stage, Mild Cognitive Impairment (MCI),
with Area Under the Curve (AUC) 0.780 while detecting AD at a late stage much more
accurately with AUC 0.917—implying its ability to also detect any other diseases.
Contributions. Our main contributions are as follows:
• MRI Slice Reconstruction: This first multiple MRI slice reconstruction approach
can predict the next 3 brain MRI slices from the previous 3 ones only for unseen
images similar to training data by combining WGAN-GP and `1 loss.
• Unsupervised Anomaly Detection: This first unsupervised anomaly detection across
different disease stages reveals that, like physicians’ way of diagnosis, massive
healthy data can reliably aid early diagnosis, such as of MCI, while also detecting
late-stage disease much more accurately by discriminating with `2 loss.
• Alzheimer’s Disease Diagnosis: This first unsupervised AD diagnosis study can
reliably detect AD and also any other diseases.
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2 Materials and Methods
2.1 OASIS-3 Dataset
We use a longitudinal dataset of 176 × 240/176 × 256 T1-weighted (T1w) 3T brain
axial MRI slices containing both normal aging subjects/AD patients extracted from the
Open Access Series of Imaging Studies-3 (OASIS-3) [13]. The 176× 240 slices are zero-
padded to reach 176 × 256 pixels. Relying on Clinical Dementia Rating (CDR) [14],
common clinical scale for the staging of dementia, the subjects are comprised of:
• Unchanged CDR = 0: Cognitively healthy population;
• CDR = 0.5: Very mild dementia (∼MCI);
• CDR = 1: Mild dementia.
• CDR = 2: Moderate dementia.
Since our dataset is longitudinal and the same subject’s CDRs may vary (e.g., CDR = 0
to CDR = 0.5), we only use scans with unchanged CDR = 0 to assure certainly healthy
scans. As CDRs and MRI scans are not always simultaneously acquired, we label MRI
scans with CDRs at the closest date. We only select brain MRI slices including hippocam-
pus/amygdala/ventricles among whole 256 axial slices per scan to avoid over-fitting from
AD-irrelevant information; the atrophy of the hippocampus/amygdala/ cerebral cortex, and
enlarged ventricles are strongly associated with AD, and thus they mainly affect the AD
classification performance of machine learning [15]. Moreover, we discard low-quality
MRI slices. The remaining dataset is divided as follows:
• Training set: Unchanged CDR = 0 (408 subjects/1, 133 scans/57, 834 slices);
• Validation set: Unchanged CDR = 0 (55 subjects/155 scans/8, 080 slices),
CDR = 0.5 (53 subjects/85 scans/4, 607 slices),
CDR = 1 (29 subjects/45 scans/2, 518 slices),
CDR = 2 (2 subjects/4 scans/160 slices);
• Test set: Unchanged CDR = 0 (113 subjects/318 scans/16, 198 slices),
CDR = 0.5 (99 subjects/168 scans/9, 206 slices),
CDR = 1 (61 subjects/90 scans/5, 014 slices),
CDR = 2 (4 subjects/6 scans/340 slices).
The same subject’s scans are included in the same dataset. The datasets are strongly biased
towards healthy scans similarly to MRI inspection in the clinical routine. During training
for reconstruction, we only use the training set containing healthy slices to conduct unsu-
pervised learning.
2.2 GAN-based Multiple Adjacent Brain MRI Slice Reconstruction
To model strong consistency in healthy brain anatomy (Fig. 1), in each scan, we re-
construct the next 3 MRI slices from the previous 3 ones using image-to-image GAN
(e.g., if a scan includes 40 slices si for i = 1, . . . , 40, we reconstruct all possible 35
setups: (si)i∈{1,2,3} 7→ (si)i∈{4,5,6}; (si)i∈{2,3,4} 7→ (si)i∈{5,6,7}; . . . ; (si)i∈{35,36,37} 7→
(si)i∈{38,39,40}). We concatenate adjacent 3 grayscale slices into 3 channels, such as in
RGB images. The GAN uses a U-Net-like [16] generator with 4 convolutional layers in
encoders and 4 deconvolutional layers in decoders respectively with skip connections as
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Figure 2: Example brain MRI slices with CDR = 0/0.5/1/2 from test sets: (a) Input 3 real slices;
(b) Ground truth next 3 real slices; (c) Next 3 slices reconstructed by U-Net; (d), (e) Next 3 slices
reconstructed by WGAN-GP without/with `1 loss.
well as a discriminator with 3 decoders. We apply batch normalization to both convolution
with LeakyReLU and deconvolution with ReLU. To confirm how reconstructed images’
realism and anatomical continuity affect anomaly detection, we compare the GAN models
with different loss functions: (i) Dice loss (i.e., a plain U-Net without the discriminator);
(ii) WGAN-GP loss; (iii) WGAN-GP loss + 100 `1 loss.
Implementation Details Considering its computational speed, U-Net training lasts for
600, 000 steps with a batch size of 64 and both GAN trainings last for 300, 000 steps with
a batch size of 32. We use 2.0× 10−4 learning rate for Adam optimizer.
2.3 Unsupervised Alzheimer’s Disease Diagnosis
During validation, we compare the following average/maximum losses per scan (i.e., 8
losses) between reconstructed/ground truth 3 slices (Fig. 1): (i) `1 loss; (ii) `2 loss; (iii)
Dice loss; (iv) Structural Similarity loss. For each model’s testing, we separately pick
the loss showing the highest AUC between CDR = 0 (i.e., healthy population) vs all the
other CDRs (i.e., dementia) during validation. As a result, we pick the average `2 loss per
scan for all models since squared error is sensitive to outliers and it always outperforms
the others. To evaluate its unsupervised AD diagnosis performance for test sets, we show
Receiver Operating Characteristics (ROCs)/AUCs between CDR = 0 vs (i) all the other
CDRs; (ii) CDR = 0.5; (iii) CDR = 1; (iv) CDR = 2. We visualize `2 loss distributions of
CDR = 0/0.5/1/2 to know how disease stages affect its discrimination.
3 Results
3.1 Reconstructed Brain MRI Slices
Fig. 2 illustrates example real MRI slices from test sets and their reconstruction by U-
Net and WGAN-GP without/with `1 loss. The WGAN-GP + `1 loss can successfully
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Figure 3: Unsupervised anomaly detection results using average `2 loss per scan on reconstructed
brain MRI slices (ROCs and AUCs): unchanged CDR = 0 (i.e., cognitively healthy population) is
compared with (a) all the other CDRs (i.e., dementia); (b) CDR = 0.5 (i.e., very mild dementia);
(c) CDR = 1 (i.e., mild dementia); (d) CDR = 2 (i.e., moderate dementia).
capture T1w-specific texture and anatomical changes from the previous 3 slices more
smoothly than the U-Net and in more detail than the WGAN-GP without `1 loss. Since the
models are trained only on healthy slices, reconstructing slices with higher CDRs tends to
comparatively fail, especially around hippocampus, amygdala, cerebral cortex, and ventri-
cles due to their insufficient atrophy after reconstruction.
3.2 Unsupervised AD Diagnosis Results
Fig. 3 shows ROC curves and their AUCs of unsupervised anomaly detection. Since
brains with higher CDRs accompany stronger anatomical atrophy from healthy brains,
their AUCs between unchanged CDR = 0 remarkably increase as CDRs increase. Clearly
outperforming the other methods in every condition, WGAN-GP + `1 loss achieves excel-
lent AUCs, especially for higher CDRs—it obtains AUC = 0.780/0.833/0.917 for CDR
= 0 vs CDR = 0.5/1/2, respectively; this experimental finding derives from `1 loss’ good
realism sacrificing diversity (i.e., generalizing well only for unseen images with a simi-
lar distribution to training images) and WGAN-GP loss’ ability to capture recognizable
structure. Fig. 4 indicates its good discrimination ability even between healthy subjects
vs MCI patients (i.e., CDR = 0 vs CDR = 0.5), which is extremely difficult even in a
supervised manner [15]. Interestingly, unlike our visual expectation, WGAN-GP without
`1 loss outperforms plain U-Net regardless of its very blurred reconstruction, showing the
superiority of GAN-based reconstruction for diagnosis.
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Figure 4: Distributions of average `2 loss per scan evaluated on brain MRI slices with CDR =
0/0.5/1/2 reconstructed by WGAN-GP + `1 loss.
4 Conclusions
Using massive healthy images, our GAN-based multiple MRI slice reconstruction can
successfully discriminate AD patients from healthy subjects for the first time in an unsu-
pervised manner; this is thanks to our two-step approach: (Reconstruction) `1 loss gen-
eralizes well only for unseen images with a similar distribution to training images while
WGAN-GP loss captures recognizable structure; (Diagnosis) `2 loss clearly discriminates
healthy/abnormal data as squared error becomes huge for outliers. Accordingly, this first
unsupervised anomaly detection across different disease stages reveals that, like physi-
cians’ way of diagnosis, large-scale healthy data can reliably aid early diagnosis, such as
of MCI, while also detecting late-stage disease much more accurately. Since our method
well detects the unseen disease hard-to-detect even in supervised learning, this should
also discover/alert any anomalies including rare disease, where supervised learning is
inapplicable. As future work, we will reconstruct slices from both the previous/next 3
slices (e.g., slices si for i = 1, . . . , 9, (si)i∈{1,2,3,7,8,9} 7→ (si)i∈{4,5,6}) for robustness,
also optimizing the number of slices (e.g., 3 slices to 1 or 5 slices). We will investigate
more reconstruction networks (e.g., GANs with attention mechanism) and more loss func-
tions for both reconstruction/diagnosis. Lastly, we plan to detect and locate various dis-
eases, including rare disease—this work only uses brain MRI slices including hippocam-
pus/amygdala/ventricles for AD diagnosis, but we may have to use all or most brain MRI
slices to also detect anomalies appeared in other brain parts.
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